1. Home
  2. JTAI vs BGLC Comparison

JTAI vs BGLC Comparison

Compare JTAI & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jet.AI Inc.

JTAI

Jet.AI Inc.

HOLD

Current Price

$6.28

Market Cap

4.6M

Sector

Finance

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.02

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JTAI
BGLC
Founded
2018
2017
Country
United States
Malaysia
Employees
8
N/A
Industry
Blank Checks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
5.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
JTAI
BGLC
Price
$6.28
$2.02
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$80.00
N/A
AVG Volume (30 Days)
258.2K
2.8K
Earning Date
05-15-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.78
EPS
N/A
N/A
Revenue
N/A
$7,424,911.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$1.92
52 Week High
$10.41
$15.19

Technical Indicators

Market Signals
Indicator
JTAI
BGLC
Relative Strength Index (RSI) 53.92 37.68
Support Level $6.05 $1.92
Resistance Level $9.24 $2.73
Average True Range (ATR) 0.55 0.06
MACD -0.31 0.00
Stochastic Oscillator 12.57 6.52

Price Performance

Historical Comparison
JTAI
BGLC

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: